期刊名：Current Oncology

期刊主页：https://www.mdpi.com/journal/curroncol

在全球癌症防控领域，泌尿系统肿瘤的发病率与疾病负担持续上升，已成为影响公共健康的重要挑战之一。本期汇总了Current Oncology期刊的编辑精选文章，重点聚焦泌尿肿瘤的最新研究进展。通过深入探讨早期筛查策略、分子分型、精准治疗及新型免疫疗法的临床应用，我们希望促进多学科间的交流与合作，以推动泌尿肿瘤诊疗水平的不断提升。

1. Identification of Early Biochemical Recurrence Predictors in High-Risk Prostate Cancer Patients Treated with Carbon-Ion Radiotherapy and Androgen Deprivation Therapy

接受碳离子放疗联合雄激素剥夺治疗的高危前列腺癌患者早期生化复发预测因素的识别

https://www.mdpi.com/1718-7729/30/10/636

Utsumi, T.; Suzuki, H.; Ishikawa, H.; Wakatsuki, M.; Okonogi, N.; Harada, M.; Ichikawa, T.; Akakura, K.; Murakami, Y.; Tsuji, H.; et al. Identification of Early Biochemical Recurrence Predictors in High-Risk Prostate Cancer Patients Treated with Carbon-Ion Radiotherapy and Androgen Deprivation Therapy. Curr. Oncol. 2023, 30, 8815-8825.

2. Incorporating Stereotactic Ablative Radiotherapy into the Multidisciplinary Management of Renal Cell Carcinoma

将立体定向消融放疗纳入肾细胞癌多学科管理体系

文章链接：https://www.mdpi.com/1718-7729/30/12/749

Raj, R.K.; Upadhyay, R.; Wang, S.-J.; Singer, E.A.; Dason, S. Incorporating Stereotactic Ablative Radiotherapy into the Multidisciplinary Management of Renal Cell Carcinoma. Curr. Oncol. 2023, 30, 10283-10298.

3. Metastatic Castration-Resistant Prostate Cancer, Immune Checkpoint Inhibitors, and Beyond

转移性去势抵抗性前列腺癌、免疫检查点抑制剂及未来发展

https://www.mdpi.com/1718-7729/30/4/323

Lanka, S.M.; Zorko, N.A.; Antonarakis, E.S.; Barata, P.C. Metastatic Castration-Resistant Prostate Cancer, Immune Checkpoint Inhibitors, and Beyond. Curr. Oncol. 2023, 30, 4246-4256.

4. Triplet Therapy in Metastatic Castrate Sensitive Prostate Cancer (mCSPC)—A Potential New Standard of Care

转移性去势敏感性前列腺癌（mCSPC）的三联治疗: —种潜在的新标准治疗方案

https://www.mdpi.com/1718-7729/30/4/332

Mittal, A.; Sridhar, S.S.; Ong, M.; Jiang, D.M. Triplet Therapy in Metastatic Castrate Sensitive Prostate Cancer (mCSPC)—A Potential New Standard of Care. Curr. Oncol. 2023, 30, 4365-4378.

5. Head-to-Head Comparison of [18F]F-choline and Imaging of Prostate-Specific Membrane Antigen, Using [18F]DCFPyL PET/CT, in Patients with Biochemical Recurrence of Prostate Cancer

在前列腺癌生化复发患者中，[18F]F-胆碱与前列腺特异性膜抗原（PSMA）显像（采用[18F]DCFPyL PET/CT）的头对头比较

https://www.mdpi.com/1718-7729/30/7/464

García-Zoghby, L.; Lucas-Lucas, C.; Amo-Salas, M.; Soriano-Castrejón, Á.M.; García-Vicente, A.M. Head-to-Head Comparison of [18F]F-choline and Imaging of Prostate-Specific Membrane Antigen, Using [18F]DCFPyL PET/CT, in Patients with Biochemical Recurrence of Prostate Cancer. Curr. Oncol. 2023, 30, 6271-6288.

6. PSMA Targeted Molecular Imaging and Radioligand Therapy for Prostate Cancer: Optimal Patient and Treatment Issues

前列腺癌的PSMA靶向分子影像及放射性配体治疗：最佳患者选择与治疗策略问题

https://www.mdpi.com/1718-7729/30/8/529

Hoshi, S.; Yaginuma, K.; Meguro, S.; Onagi, A.; Matsuoka, K.; Hata, J.; Sato, Y.; Akaihata, H.; Kataoka, M.; Ogawa, S.; et al. PSMA Targeted Molecular Imaging and Radioligand Therapy for Prostate Cancer: Optimal Patient and Treatment Issues. Curr. Oncol. 2023, 30, 7286-7302.

7. Detecting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions Using T2w-Derived Radiomics Feature Maps in 3T Prostate MRI

利用3T前列腺MRI中T2加权影像衍生的影像组学特征图检测PI-RADS 3病变中的临床显著性前列腺癌

https://www.mdpi.com/1718-7729/31/11/503

Jensen, L.J.; Kim, D.; Elgeti, T.; Steffen, I.G.; Schaafs, L.-A.; Haas, M.; Kurz, L.J.; Hamm, B.; Nagel, S.N. Detecting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions Using T2w-Derived Radiomics Feature Maps in 3T Prostate MRI. Curr. Oncol. 2024, 31, 6814-6828.

8. Real-World Oncological Outcomes of Nivolumab Plus Ipilimumab in Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study in Japan

纳武利尤单抗联合伊匹木单抗治疗晚期或转移性肾细胞癌的真实世界肿瘤学结局：一项日本多中心回顾性队列研究

https://www.mdpi.com/1718-7729/31/12/583

Taniguchi, T.; Iinuma, K.; Kawada, K.; Ishida, T.; Takagi, K.; Tomioka, M.; Kawase, M.; Kawase, K.; Nakane, K.; Tobisawa, Y.; et al. Real-World Oncological Outcomes of Nivolumab Plus Ipilimumab in Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study in Japan. Curr. Oncol. 2024, 31, 7914-7923.

9. Salvage High-Intensity Focused Ultrasound for Prostate Cancer after Radiation Failure: A Narrative Review

放疗失败后前列腺癌的挽救性高强度聚焦超声治疗：一项叙述性综述

https://www.mdpi.com/1718-7729/31/7/270

Sobhani, S.; Dadabhoy, A.; Ghoreifi, A.; Lebastchi, A.H. Salvage High-Intensity Focused Ultrasound for Prostate Cancer after Radiation Failure: A Narrative Review. Curr. Oncol. 2024, 31, 3669-3681.

10. Trop-2 in Upper Tract Urothelial Carcinoma

Trop-2 在上尿路尿路上皮癌中的研究进展

https://www.mdpi.com/1718-7729/29/6/312

Tomiyama, E.; Fujita, K.; Nakano, K.; Kuwahara, K.; Minami, T.; Kato, T.; Hatano, K.; Kawashima, A.; Uemura, M.; Takao, T.; et al. Trop-2 in Upper Tract Urothelial Carcinoma. Curr. Oncol. 2022, 29, 3911-3921.

期刊介绍

主编：Prof. Dr. Shahid Ahmed, University of Saskatchewan; Saskatoon Cancer Center, Canada

Current Oncology （ISSN 1718-7729）自1994年创刊以来，致力于通过发表临床相关研究并直接应用于肿瘤学实践，推动癌症护理和治疗的发展。该期刊发表的文章通常包含与临床肿瘤学实践直接相关的信息，并具有应用于当前或未来癌症医学实践的明确潜力。Current Oncology 与多个重要的癌症协会合作，提供了一个分享肿瘤学科学进展的全球平台。